MEZAGITAMAB

UNII:	0XMR8L9LOL
Formula:
Preferred Substance Name:	MEZAGITAMAB
GSRS Full Record:	0XMR8L9LOL i

2227490-52-8
ANTI-CD38 MONOCLONAL ANTIBODY TAK-079
HUMAN IGG1 ANTI CD38 MONOCLONAL ANTIBODY TAK-079
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD38 ANTIGEN) (HUMAN MONOCLONAL AB79 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AB79 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-LAMBDA, ANTI-(HOMO SAPIENS ADP-RIBOSYL CYCLASE/CYCLIC ADP-RIBOSE HYDROLASE 1 (2'-PHOSPHO-ADP-RIBOSYL CYCLASE, ANTIGENE CD38))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN HUMANIZED(1-453) (HOMO SAPIENS VH (IGHV3-23*01 (89%) (IGHD)-IGHJ1*01 (93%)) (8.8.16) (1-123)-HOMO SAPIENS IGHG1*03 (124-453)) (226-215')-DISULFIDE WITH .LAMBDA. LIGHT CHAIN HUMANIZED (1'-216') (V-LAMBDA (HOMO SAPIENS IGLV1-47*01 (92%) IGLJ2*01)(8.3.11) (1'-110')-HOMO SAPIENS IGLC1*02 (111'-216')), DIMER (232-232'':235-235'')-BISDISULFIDE
MEZAGITAMAB [INN]
MEZAGITAMAB [USAN]
MEZAGITAMAB [WHO-DD]
TAK079
TAK-079

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

MEZAGITAMAB

Synonyms and Mappings

Resources